LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

The MKULTRA Project involved some of the most controversial experiments aimed at reprogramming and controlling the human mind ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

Metabolic reprogramming is the hallmark of malignant tumors. Both metabolic phenotype and metabolic dependence are changed during the development of cancer from precancerous tissue to local invasion ...